| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gemini Therapeutics, Inc. /DE | 10%+ Owner | Common Stock | 5,000,000 | $338,250,000 | $67.65 | 26 Oct 2022 | Holding of BML Investment Partners, L.P. |
| IMARA Inc. | 10%+ Owner | Common Stock | 1,767,774 | $26,755,259 | $15.14 | 04 Jan 2023 | Holding of BML Investment Partners, L.P. |
| Aclaris Therapeutics, Inc. | 10%+ Owner | Common Stock | 14,250,000 | $17,731,275 | $1.24 | 05 Aug 2024 | Holding of BML Investment Partners, L.P |
| Gemini Therapeutics, Inc. /DE | 10%+ Owner | Common Stock | 247,500 | $16,743,375 | $67.65 | 26 Oct 2022 | Direct |
| Cyteir Therapeutics, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 3,654,053 | $10,779,456 | $2.95 | 20 Mar 2024 | Holding of BML Investment Partners, L.P |
| Adverum Biotechnologies, Inc. | 10%+ Owner | Common Stock | 1,958,080 | $8,213,558 | $4.19 | 04 Dec 2025 | Holdings of BML Investment Partners, L.P. |
| Satsuma Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 6,440,000 | $5,860,400 | $0.9100 | 21 Nov 2022 | Holding of BML Investment Partners, L.P. |
| IMARA Inc. | 10%+ Owner | Common Stock | 230,000 | $3,481,050 | $15.14 | 03 Jan 2023 | Direct |
| AN2 Therapeutics, Inc. | 10%+ Owner | Common Stock | 3,017,432 | $3,289,000 | $1.09 | 28 May 2025 | Holding of BML Investment Partners, L.P. |
| Metacrine, Inc. | 10%+ Owner | Common Stock | 6,160,570 | $2,895,468 | $0.4700 | 21 Dec 2022 | Holding of BML Investment Partners, L.P. |
| Cyteir Therapeutics, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 335,000 | $988,250 | $2.95 | 20 Mar 2024 | Direct |
| RETRACTABLE TECHNOLOGIES INC | 10%+ Owner | Common Stock | 688,575 | $846,947 | $1.23 | 29 Dec 2022 | Holding of BML Investment Partners, L.P. |
| Adverum Biotechnologies, Inc. | 10%+ Owner | Common Stock | 191,800 | $817,068 | $4.26 | 04 Dec 2025 | Direct |
| Tectonic Therapeutic, Inc. | Former 10% owner of AVROBIO | Common Stock | 400,355 | $520,462 | $1.30 | 20 Jun 2024 | Holding of BML Investment Partners, L.P, |
| Reneo Pharmaceuticals, Inc. | Former 10% owner of RPHM | Common Stock | 345,739 | $517,364 | $1.50 | 07 Oct 2024 | Holdings of BML Investment Partners, L.P. |
| RETRACTABLE TECHNOLOGIES INC | 10%+ Owner | Common Stock | 387,500 | $476,625 | $1.23 | 29 Dec 2022 | Direct |
| Talis Biomedical Corp | 10%+ Owner | Common Stock | 248,702 | $369,074 | $1.48 | 06 Sep 2024 | Holding of BML Investment Partners, L.P. |
| Metacrine, Inc. | 10%+ Owner | Common Stock | 600,000 | $282,000 | $0.4700 | 19 Dec 2022 | Direct |
| Reneo Pharmaceuticals, Inc. | Former 10% owner of RPHM | Common Stock | 102,076 | $152,747 | $1.50 | 07 Oct 2024 | Direct |
| Satsuma Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 150,000 | $136,500 | $0.9100 | 21 Nov 2022 | Direct |
| Tectonic Therapeutic, Inc. | Former 10% owner of AVROBIO | Common Stock | 33,333 | $43,333 | $1.30 | 20 Jun 2024 | Direct |
| ASTROTECH Corp | 10%+ Owner | Common Stock | 0 | $0 | $5.83 | 03 Oct 2025 | Direct |
| ASTROTECH Corp | 10%+ Owner | Common Stock | 0 | $0 | $7.13 | 03 Oct 2025 | Holdings of BML Investment Partners, L.P |
| RETRACTABLE TECHNOLOGIES INC | 10%+ Owner | Put Option (obligation to buy) | 0 | 28 Nov 2022 | Holding of BML Investment Partners, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies, Inc. | 04 Dec 2025 | 1 | -$2,200,372 | 4 | 10%+ Owner | 05 Dec 2025, 18:20 |
| ADVM | Adverum Biotechnologies, Inc. | 01 Dec 2025 | 3 | -$2,407,833 | 4 | 10%+ Owner | 03 Dec 2025, 21:39 |
| ASTC | ASTROTECH Corp | 03 Oct 2025 | 2 | -$1,625,071 | 4 | 10%+ Owner | 07 Oct 2025, 20:51 |
| ANTX | AN2 Therapeutics, Inc. | 12 Jun 2025 | 1 | -$218,000 | 4 | 10%+ Owner | 16 Jun 2025, 15:40 |
| ANTX | AN2 Therapeutics, Inc. | 28 May 2025 | 4 | -$2,872,477 | 4 | 10%+ Owner | 30 May 2025, 17:40 |
| ADVM | Adverum Biotechnologies, Inc. | 22 Apr 2025 | 2 | +$1,048,950 | 4 | 10%+ Owner | 24 Apr 2025, 09:35 |
| ADVM | Adverum Biotechnologies, Inc. | 31 Mar 2025 | 2 | +$147,076 | 4 | 10%+ Owner | 02 Apr 2025, 18:07 |
| ADVM | Adverum Biotechnologies, Inc. | 26 Mar 2025 | 2 | +$188,931 | 4/A | 10%+ Owner | 28 Apr 2025, 15:31 |
| ADVM | Adverum Biotechnologies, Inc. | 26 Mar 2025 | 2 | +$188,931 | 4 | 10%+ Owner | 28 Apr 2025, 15:24 |
| ADVM | Adverum Biotechnologies, Inc. | 18 Mar 2025 | 4 | +$587,575 | 4 | 10%+ Owner | 20 Mar 2025, 20:02 |
| ADVM | Adverum Biotechnologies, Inc. | 26 Feb 2025 | 3 | +$1,439,087 | 4 | 10%+ Owner | 28 Feb 2025, 16:04 |
| OKUR | OnKure Therapeutics, Inc. | 07 Oct 2024 | 2 | $0 | 4 | Former 10% owner of RPHM | 09 Oct 2024, 11:25 |
| RPHM | Reneo Pharmaceuticals, Inc. | 24 Sep 2024 | 2 | +$144,738 | 4 | 10%+ Owner | 26 Sep 2024, 09:33 |
| RPHM | Reneo Pharmaceuticals, Inc. | 17 Sep 2024 | 2 | +$76,237 | 4 | 10%+ Owner | 19 Sep 2024, 11:02 |
| RPHM | Reneo Pharmaceuticals, Inc. | 12 Sep 2024 | 3 | +$484,344 | 4 | 10%+ Owner | 16 Sep 2024, 16:15 |
| TLIS | Talis Biomedical Corp | 05 Sep 2024 | 2 | +$44,240 | 4 | 10%+ Owner | 09 Sep 2024, 16:24 |
| TLIS | Talis Biomedical Corp | 03 Sep 2024 | 1 | +$2,000 | 4 | 10%+ Owner | 05 Sep 2024, 11:57 |
| TLIS | Talis Biomedical Corp | 30 Aug 2024 | 1 | +$642 | 4 | 10%+ Owner | 04 Sep 2024, 20:19 |
| TLIS | Talis Biomedical Corp | 28 Aug 2024 | 2 | +$56,137 | 4 | 10%+ Owner | 28 Aug 2024, 16:45 |
| TLIS | Talis Biomedical Corp | 14 Aug 2024 | 0 | $0 | 3 | 10%+ Owner | 14 Aug 2024, 21:13 |
| ANTX | AN2 Therapeutics, Inc. | 14 Aug 2024 | 1 | +$1,560,000 | 4 | 10%+ Owner | 14 Aug 2024, 20:24 |
| RPHM | Reneo Pharmaceuticals, Inc. | 13 Aug 2024 | 2 | +$380,598 | 4 | 10%+ Owner | 14 Aug 2024, 20:48 |
| ANTX | AN2 Therapeutics, Inc. | 09 Aug 2024 | 0 | $0 | 3 | 10%+ Owner | 12 Aug 2024, 16:58 |
| ACRS | Aclaris Therapeutics, Inc. | 02 Aug 2024 | 2 | +$472,757 | 4 | 10%+ Owner | 05 Aug 2024, 15:57 |
| ADVM | Adverum Biotechnologies, Inc. | 30 Jul 2024 | 1 | +$613,470 | 4 | 10%+ Owner | 31 Jul 2024, 16:19 |
| ACRS | Aclaris Therapeutics, Inc. | 30 Jul 2024 | 2 | +$359,010 | 4 | 10%+ Owner | 31 Jul 2024, 16:10 |
| ACRS | Aclaris Therapeutics, Inc. | 18 Jul 2024 | 3 | +$201,808 | 4 | 10%+ Owner | 22 Jul 2024, 16:03 |
| ADVM | Adverum Biotechnologies, Inc. | 18 Jul 2024 | 2 | +$1,785,662 | 4 | 10%+ Owner | 18 Jul 2024, 21:16 |
| ADVM | Adverum Biotechnologies, Inc. | 17 Jul 2024 | 0 | $0 | 3 | 10%+ Owner | 18 Jul 2024, 21:16 |
| ACRS | Aclaris Therapeutics, Inc. | 02 Jul 2024 | 3 | +$405,894 | 4 | 10%+ Owner | 05 Jul 2024, 14:46 |
| ACRS | Aclaris Therapeutics, Inc. | 27 Jun 2024 | 4 | +$1,742,075 | 4 | 10%+ Owner | 01 Jul 2024, 13:39 |
| TECX | Tectonic Therapeutic, Inc. | 20 Jun 2024 | 2 | $0 | 4 | Former 10% owner of AVROBIO | 25 Jun 2024, 13:42 |
| ACRS | Aclaris Therapeutics, Inc. | 14 Jun 2024 | 3 | +$628,206 | 4 | 10%+ Owner | 18 Jun 2024, 16:04 |
| ACRS | Aclaris Therapeutics, Inc. | 11 Jun 2024 | 4 | +$1,781,897 | 4 | 10%+ Owner | 13 Jun 2024, 18:04 |
| RPHM | Reneo Pharmaceuticals, Inc. | 14 May 2024 | 2 | +$639,578 | 4 | 10%+ Owner | 16 May 2024, 08:58 |
| RPHM | Reneo Pharmaceuticals, Inc. | 14 May 2024 | 0 | $0 | 3 | 10%+ Owner | 16 May 2024, 08:56 |
| AVRO | AVROBIO, Inc. | 13 May 2024 | 3 | +$971,493 | 4 | 10%+ Owner | 15 May 2024, 11:21 |
| AVRO | AVROBIO, Inc. | 13 May 2024 | 0 | $0 | 3/A | 10%+ Owner | 15 May 2024, 10:51 |
| AVRO | AVROBIO, Inc. | 13 May 2024 | 0 | $0 | 3 | 10%+ Owner | 15 May 2024, 10:31 |
| CYT | Cyteir Therapeutics, Inc. | 20 Mar 2024 | 1 | +$503,238 | 4 | 10%+ Owner | 25 Mar 2024, 11:05 |
| CYT | Cyteir Therapeutics, Inc. | 19 Mar 2024 | 1 | +$342,469 | 4 | 10%+ Owner | 19 Mar 2024, 16:19 |
| CYT | Cyteir Therapeutics, Inc. | 15 Mar 2024 | 0 | $0 | 3 | 10%+ Owner | 19 Mar 2024, 16:09 |
| ACRS | Aclaris Therapeutics, Inc. | 07 Feb 2024 | 0 | $0 | 3 | 10%+ Owner | 08 Feb 2024, 10:47 |
| ELVN | IMARA Inc. | 03 Jan 2023 | 1 | -$5,000,000 | 4/A | 10%+ Owner | 05 Jan 2023, 19:03 |
| ELVN | IMARA Inc. | 30 Dec 2022 | 1 | -$80,800 | 4 | 10%+ Owner | 30 Dec 2022, 16:42 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 29 Dec 2022 | 1 | -$4,800,000 | 4 | 10%+ Owner | 29 Dec 2022, 16:43 |
| ELVN | IMARA Inc. | 28 Dec 2022 | 2 | -$80,800 | 4 | 10%+ Owner | 29 Dec 2022, 17:18 |
| ELVN | IMARA Inc. | 22 Dec 2022 | 2 | -$203,000 | 4 | 10%+ Owner | 27 Dec 2022, 08:34 |
| MTCR | Metacrine, Inc. | 19 Dec 2022 | 3 | +$107,594 | 4 | 10%+ Owner | 21 Dec 2022, 16:49 |
| ASTC | ASTROTECH Corp | 02 Dec 2022 | 1 | +$65,599 | 4 | 10%+ Owner | 02 Dec 2022, 17:38 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 28 Nov 2022 | 2 | -$505,524 | 4 | 10%+ Owner | 30 Nov 2022, 19:14 |
| ASTC | ASTROTECH Corp | 23 Nov 2022 | 1 | +$24,652 | 4 | 10%+ Owner | 25 Nov 2022, 10:02 |
| STSA | Satsuma Pharmaceuticals, Inc. | 21 Nov 2022 | 1 | +$106,740 | 4 | 10%+ Owner | 23 Nov 2022, 08:38 |
| ASTC | ASTROTECH Corp | 16 Nov 2022 | 3 | +$144,940 | 4 | 10%+ Owner | 18 Nov 2022, 15:02 |
| STSA | Satsuma Pharmaceuticals, Inc. | 14 Nov 2022 | 3 | +$4,394,273 | 4 | 10%+ Owner | 16 Nov 2022, 15:32 |
| STSA | Satsuma Pharmaceuticals, Inc. | 14 Nov 2022 | 0 | $0 | 3 | 10%+ Owner | 16 Nov 2022, 14:48 |
| MTCR | Metacrine, Inc. | 07 Nov 2022 | 3 | +$68,074 | 4 | 10%+ Owner | 09 Nov 2022, 17:29 |
| MTCR | Metacrine, Inc. | 27 Oct 2022 | 2 | +$317,328 | 4 | 10%+ Owner | 31 Oct 2022, 13:47 |
| IRON | Gemini Therapeutics, Inc. /DE | 26 Oct 2022 | 1 | -$47,025 | 4 | 10%+ Owner | 27 Oct 2022, 16:23 |
| MTCR | Metacrine, Inc. | 24 Oct 2022 | 3 | +$443,100 | 4 | 10%+ Owner | 26 Oct 2022, 16:45 |
| MTCR | Metacrine, Inc. | 24 Oct 2022 | 0 | $0 | 3 | 10%+ Owner | 26 Oct 2022, 16:30 |
| ASTC | ASTROTECH Corp | 14 Oct 2022 | 2 | +$81,838 | 4 | 10%+ Owner | 18 Oct 2022, 14:02 |
| ASTC | ASTROTECH Corp | 23 Sep 2022 | 3 | +$156,608 | 4 | 10%+ Owner | 27 Sep 2022, 18:12 |
| ASTC | ASTROTECH Corp | 01 Sep 2022 | 2 | +$117,304 | 4 | 10%+ Owner | 07 Sep 2022, 09:21 |
| ASTC | ASTROTECH Corp | 24 Aug 2022 | 0 | $0 | 3 | 10%+ Owner | 25 Aug 2022, 11:36 |
| ASTC | ASTROTECH Corp | 23 Aug 2022 | 2 | +$218,899 | 4 | 10%+ Owner | 25 Aug 2022, 11:52 |
| ELVN | IMARA Inc. | 16 Jun 2022 | 1 | +$92,243 | 4 | 10%+ Owner | 21 Jun 2022, 09:48 |
| ELVN | IMARA Inc. | 03 Jun 2022 | 2 | +$38,027 | 4 | 10%+ Owner | 07 Jun 2022, 16:12 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 23 May 2022 | 2 | +$252,898 | 4 | 10%+ Owner | 25 May 2022, 16:10 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 17 May 2022 | 3 | +$534,857 | 4 | 10%+ Owner | 19 May 2022, 14:48 |
| ELVN | IMARA Inc. | 16 May 2022 | 2 | +$50,413 | 4 | 10%+ Owner | 18 May 2022, 11:00 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 12 May 2022 | 3 | +$553,721 | 4 | 10%+ Owner | 16 May 2022, 16:02 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 09 May 2022 | 3 | +$281,044 | 4 | 10%+ Owner | 11 May 2022, 18:28 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 28 Apr 2022 | 3 | +$1,603,219 | 4 | 10%+ Owner | 02 May 2022, 16:09 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 28 Apr 2022 | 0 | $0 | 3 | 10%+ Owner | 02 May 2022, 16:03 |
| ELVN | IMARA Inc. | 21 Apr 2022 | 2 | +$783,840 | 4 | 10%+ Owner | 25 Apr 2022, 11:05 |
| ELVN | IMARA Inc. | 21 Apr 2022 | 0 | $0 | 3 | 10%+ Owner | 25 Apr 2022, 10:51 |
| IRON | Gemini Therapeutics, Inc. /DE | 11 Apr 2022 | 4 | +$1,337,929 | 4 | 10%+ Owner | 13 Apr 2022, 16:09 |
| IRON | Gemini Therapeutics, Inc. /DE | 11 Apr 2022 | 0 | $0 | 3 | 10%+ Owner | 13 Apr 2022, 16:06 |